Nanometer fluorescent crystal near-infrared light donor and acceptor pair for background-free homogeneous detection and implementation method of nanometer fluorescent crystal near-infrared light donor and acceptor pair
The near-infrared FRET sensor constructed through rare earth nanoprobes solves the problems of low detection accuracy and sensitivity in complex biological samples, and realizes high sensitivity background-free homogeneous detection, which has the advantages of simple operation and high speed and high specificity.
Patent Information
- Application Number
- CN202411003718.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2024-06-06
- Filing Date
- 2024-07-25
- Publication Date
- 2024-11-15
AI Technical Summary
The existing homogeneous detection methods based on FRET have problems such as light, poor chemical stability, low sensitivity and serious background interference in complex biological samples, which affect the detection accuracy.
The near-infrared FRET sensor was constructed using rare earth nanoprobes. By designing rare earth fluoride nanocrystals co-doped with Nd3+ and Yb3+ as donor and Yb3+ as acceptors, the distance and spectrum of donor acceptors are optimized. Overlap, improve FRET efficiency and achieve high sensitivity detection by specific antibody or antigen binding.
It realizes background-free homogeneous detection of complex samples such as urine, feces, whole blood, etc., and has the advantages of simple operation, short detection time, fast, high specificity, high selectivity and high throughput.
Smart Images

Figure CN118962116A_ABST
Abstract
Description
Technical Field
[0001] The present invention belongs to the technical field of analysis and in vitro detection, and specifically relates to a nano fluorescent crystal near-infrared light donor and acceptor pair for background-free homogeneous detection and an implementation method thereof. Background Art
[0002] Homogeneous detection based on fluorescence resonance energy transfer (FRET) technology is a detection technology that uses the FRET phenomenon between donors and acceptors to determine the content of biological targets and the interaction between different molecules. FRET is a non-radiative energy transfer process between two fluorescent molecules, in which one fluorescent molecule transfers energy to another fluorescent molecule through non-radiative interaction, causing the second fluorescent molecule to emit a fluorescent signal. Homogeneous detection based on FRET technology has the advantages of simple operation, no need for complex instruments, no need for complex elution process, fast detection speed, wide application range, and high sensitivity. In recent years, this technology has become a hot area of concern and has received extensive research and application attention. Although the research on this technology has made certain progress, the existing homogeneous detection method based on FRET still has a big pain point problem: the color and turbidity of the sample to be detected still seriously interfere with the accuracy and sensitivity of the homogeneous detection. Therefore, how to overcome the interference of the color and turbidity of the sample to be detected on the accuracy and sensitivity of the homogeneous detection is an urgent problem to be solved.
[0003] The FRET phenomenon refers to non-radiative energy transfer between molecules that are very close (<10nm), so choosing suitable donors and acceptors is extremely important for achieving rapid and highly sensitive homogeneous detection. For donors, the choice has gradually expanded from traditional fluorescent proteins and organic small molecule dyes to inorganic nanoparticles. Currently, rare earth-doped nanoparticles (LnNPs) are an emerging donor material. The excitation light source of rare earth-doped nanoparticles can be multiple spectral ranges such as ultraviolet, visible to near-infrared, and the emission light also includes multiple spectral ranges such as ultraviolet, visible to near-infrared, etc. It has the advantages of multi-band emission, narrow emission peak width, and long fluorescence lifetime. The donor can be designed in various ways according to needs. It also has excellent light, chemical stability and anti-interference ability, and is an excellent type of fluorescent probe. Compared with traditional donor materials, the excitation and emission of near-infrared light by rare earth-doped down-conversion nanoparticles (DCNPs) have lower background fluorescence and scattering interference. Therefore, more sensitive sensors can be constructed in more complex biological samples (such as urine, saliva, feces, etc.). DCNPs are a more ideal donor material.
[0004] The acceptor material should be selected to match the donor material as much as possible to achieve a high FRET efficiency. In addition, the light and chemical stability of the acceptor material and the crosstalk between its emission spectrum and the emission of the donor material should be considered to make the constructed near-infrared FRET sensor have excellent performance. Therefore, it is very important to choose a suitable rare earth-doped acceptor material and meet the detection needs of various biological targets currently in existence.
[0005] In the FRET process between donor and acceptor, the distance between the donor and acceptor and the degree of spectral overlap are the main factors affecting the efficiency. Therefore, the FRET efficiency can be improved by shortening the distance between the donor and acceptor and increasing the spectral overlap area of the donor and acceptor. However, DCNP particles are generally 10 to 50 nm, and the acceptor will only interact with the donor luminescence center distributed closer to the surface. The luminescence center that does not interact will emit light independently, resulting in very low FRET efficiency. At the same time, the luminescence of some rare earth luminescence centers in the near-infrared region is more easily quenched by water, which requires a rare earth element that is relatively unaffected by water. Therefore, it is crucial to select suitable RENPs as the donor material of the near-infrared FRET system and perform homogeneous detection of biomarkers in complex samples. In addition, for the acceptor, a material with a large overlap area with the donor luminescence spectrum is required as much as possible, so as to effectively improve the FRET efficiency.
[0006] In summary, it can be seen that designing a near-infrared FRET sensor completely based on rare earth nanoprobes and constructing a near-infrared FRET sensor with higher photochemical stability, stronger anti-interference ability and wider application range are crucial to achieve highly sensitive homogeneous detection of life markers in complex biological samples. Summary of the invention
[0007] In view of the problems of poor light and chemical stability, low sensitivity, background interference, etc. in the existing FRET-based homogeneous detection methods, the present invention provides a nano-fluorescent crystal near-infrared light donor and acceptor pair composed entirely of rare earth nanoprobes, and based on this, constructs a near-infrared fluorescence resonance energy transfer (FRET) sensor that can be used for high-sensitivity homogeneous detection, which realizes high-sensitivity homogeneous detection of complex samples such as urine, feces, whole blood, pleural effusion, sewage and food safety detection samples, and has the advantages of simple operation, short detection time, and background-free detection.
[0008] In order to achieve the above object, the technical solution adopted by the present invention is:
[0009] In a first aspect, the present invention provides a near-infrared FRET biosensor based on rare earth ion doped nanocrystals, wherein the near-infrared FRET biosensor comprises a probe 1 labeled with an antibody or an antigen and a probe 2 labeled with an antibody or an antigen, wherein the antibody and the antigen are an antigen-antibody pair capable of undergoing a specific binding reaction; the probe 1 is Nd 3+ With Yb 3+ Co-doped rare earth fluoride nanocrystals, specifically NaLnF4@NaLnF4:Ndx% / Yby%, with a core-shell structure, wherein x=40, y=10; the probe 2 is Yb 3+ Doped rare earth fluoride nanocrystals, specifically NaLnF4:Ybx%, wherein x=100.
[0010] The second aspect of the present invention provides a method for constructing a near-infrared FRET biosensor based on rare earth ion-doped nanocrystals as described in the first aspect, characterized in that it comprises the following steps:
[0011] S1. Preparation of Nd 3+ With Yb 3+ Co-doped rare earth fluoride nanocrystals:
[0012] S11. Prepare the inert core NaLnF4 by the method of S11-1 or S11-2:
[0013] S11-1, rare earth acetate, oleic acid (OA) and 1-octadecene (ODE) are uniformly mixed, heated to a first temperature under an inert atmosphere, reacted for 45±15 min, cooled, added with a methanol solution containing sodium hydroxide (NaOH) and ammonium fluoride (NH4F), heated to a second temperature under an inert atmosphere, and after the methanol, oxygen and water in the system are completely removed, heated to a third temperature again, reacted for 75±15 min, cooled, centrifuged, collected the product, washed with ethanol for 1-3 times, and dispersed in a dispersant to obtain NaLnF4 nanoparticles;
[0014] S11-2, uniformly mixing trifluoroacetic acid rare earth salt, sodium trifluoroacetate, OA and ODE, heating to a first temperature under an inert atmosphere, reacting for 20±15 min, heating to a second temperature under an inert atmosphere, reacting for 45±15 min, cooling and centrifuging to collect the product, washing with ethanol 1-3 times, and dispersing in a dispersant to obtain NaLnF4 nanoparticles;
[0015] S12, using the method of S12-1 or S12-2 to prepare core-shell structure NaLnF4@NaLnF4:Ndx% / Yby% nanocrystals:
[0016] S12-1, mixing rare earth acetate, OA and ODE uniformly, heating to a first temperature under an inert atmosphere, reacting for 45±15 min, cooling, adding a methanol solution containing NaOH and NH4F and the NaLnF4 nanoparticles synthesized in S11, heating to a second temperature under an inert atmosphere, and heating to a third temperature again after the methanol, oxygen and water in the system are completely removed, reacting for 75±15 min, cooling, collecting the product by centrifugation, washing with ethanol for 1-3 times, and dispersing in a dispersant to obtain NaLnF4@NaLnF4:Ndx% / Yby% nanoparticles;
[0017] S12-2, uniformly mix trifluoroacetic acid rare earth salt, sodium trifluoroacetate, OA and ODE, heat to a first temperature under an inert atmosphere, react for 20±15 min, add a methanol solution containing NaOH and NH4F and the NaLnF4 nanoparticles synthesized in S3 after cooling, heat to a second temperature under an inert atmosphere, react for 45±15 min, collect the product by centrifugation after cooling, wash with ethanol for 1-3 times, and disperse in a dispersant to obtain the NaLnF4@NaLnF4:Ndx% / Yby%;
[0018] S2, Synthesis of Yb 3+ Doped rare earth fluoride nanocrystals:
[0019] Rare earth acetate, OA, ODE and oleylamine (OM) are uniformly mixed, heated to a first temperature under an inert atmosphere, reacted for 45±15 minutes, cooled, added with a methanol solution containing NaOH and NH4F, heated to a second temperature under an inert atmosphere, and after the methanol, oxygen and water in the system are completely removed, heated to a third temperature again, reacted for 45±15 minutes, cooled, centrifuged, collected the product, washed with ethanol 2-3 times, and dispersed in a dispersant to obtain NaLnF4:Ybx% particles;
[0020] S3, Nd of step S1 3+ With Yb 3+ The co-doped rare earth fluoride nanocrystals are labeled with antibodies or antigens, thereby obtaining probes 1 labeled with antibodies or antigens;
[0021] S4, Yb in step S2 3+ The doped rare earth fluoride nanocrystals are labeled with antibodies or antigens to obtain probes 2 labeled with antibodies or antigens.
[0022] Preferably, in S11-1, the rare earth element is yttrium (Y), the inert gas is nitrogen, the first temperature is 155±15°C, the second temperature is 120±20°C, the third temperature is 300±20°C, the dispersant is cyclohexane, and the amount of the rare earth acetate, oleic acid and 1-octadecene is 0.25~1.0mmol:5~10mL:10~20mL; in S11-2, the rare earth element is yttrium (Y), the inert gas is nitrogen, the first temperature is 120±20°C, the second temperature is 300±20°C, the dispersant is cyclohexane, and the amount of the rare earth acetate, oleic acid and 1-octadecene is 0.25~1.0mmol:5~10mL:10~20mL.
[0023] Preferably, in S12-1, the rare earth element is yttrium (Y), neodymium (Nd) or ytterbium (Yb), the inert gas is nitrogen, the first temperature is 155±15°C, the second temperature is 120±20°C, the third temperature is 300±20°C, the dispersant is cyclohexane, and the amount of the acetate, oleic acid and 1-octadecene of the rare earth element is 0.25~1.0mmol:5~10mL:10~20mL; in S12-2, the rare earth element is yttrium (Y), neodymium (Nd) or ytterbium (Yb), the inert gas is nitrogen, the first temperature is 120±20°C, the second temperature is 300±20°C, and the dispersant is cyclohexane; the amount of the acetate, oleic acid and 1-octadecene of the rare earth element is 0.25~1.0mmol:5~10mL:10~20mL.
[0024] Preferably, in S2, the rare earth element is ytterbium (Yb), the inert gas is nitrogen, the first temperature is 155±15°C, the second temperature is 120±20°C, the third temperature is 300±15°C, the dispersant is cyclohexane, and the ratio of rare earth acetate, oleic acid, 1-octadecene and oleylamine is 0.25~1.0mmol:1~5mL:2~10mL:1~5mL.
[0025] Preferably, step S3 is to 3+ With Yb 3+ The method for labeling antibodies or antigens with co-doped rare earth fluoride nanocrystals is as follows: using the Nd 3+ With Yb 3+ The surface of the co-doped rare earth fluoride nanocrystal has a layer of OA ligands, and the surface of the nanocrystal is coated with a carboxyl polymer by using a ligand exchange method, and then mixed with an activator, reacted, and centrifuged. The obtained precipitate is dispersed in buffer A, washed with buffer A 1-3 times, and then an antibody or antigen is added to the buffer solution. After mixing, buffer B containing 1% bovine serum albumin (BSA) is added to continue the reaction. After the reaction is completed, centrifugation and washing are performed to obtain a solution of rare earth doped luminescent nanocrystals labeled with antibodies;
[0026] Preferably, step S4 is to 3+ The method for labeling antibodies or antigens with rare earth fluoride nanocrystals doped with the Yb 3+ Rare earth fluoride nanocrystals are doped, and the surface of the nanocrystals is coated with a carboxyl polymer using a ligand exchange method, and then mixed with an activator, reacted, and centrifuged. The resulting precipitate is dispersed in buffer A, washed with buffer A for 1-3 times, and then an antibody or antigen is added to the buffer solution. After mixing, buffer B containing 2% BSA is added to continue the reaction. After the reaction is completed, the solution is centrifuged, washed, and redispersed in buffer C to obtain a solution of rare earth doped luminescent nanocrystals labeled with an antigen.
[0027] More preferably, in S3 and S4, the buffer A is a 2-morpholineethanesulfonic acid (MES) solution with a concentration of 0.10 mol / L and a pH of 6.0; the buffer B is a glycine buffer with a pH of 8.0; and the buffer C is a tromethamine (Tris) buffer with a pH of 7.4.
[0028] More preferably, in S3 and S4, the antibodies include adenovirus (AdV) antibody 1, VD antibody, MOP antibody (Ab MOP ), acetylcholine antibody or human chorionic gonadotropin (β-HCG) antibody 1, etc.; the antigens include adenovirus (AdV) antigen 2, VD antigen, MOP antigen (Ag MOP ), acetylcholine antigen or human chorionic gonadotropin (β-HCG) antibody 2, etc.
[0029] In theory, any antigen-antibody, interacting protein pair that can undergo specific binding reaction, or double antibody pair that can interact with the antigen to be tested can be used: for example, the antibody linked to the donor can be VD antibody, MOP antibody (Ab MOP ), acetylcholine antibodies, etc., and the receptor-bound antigens can be VD antigens, MOP antigens (Ag MOP ), acetylcholine antigen, etc.; at the same time, the donor-linked antibody can also be adenovirus (AdV) antibody 1, dengue antibody 1, etc., and the receptor-linked antigen can also be adenovirus (AdV) antigen 2, dengue antigen 2, etc.
[0030] More preferably, in steps S3 and S4, the mixing with the activator (i.e., the activation step) is: dispersing probe 1 or probe 2 in a MES solution, and then adding EDC [1-ethyl-(3-dimethylaminopropyl)carbodiimide hydrochloride in a MES solution] and NHS (N-hydroxysuccinimide in a MES solution), wherein the concentrations of EDC and NHS are both 10 mg / mL, and the volume ratio is 3:5.
[0031] More preferably, in steps S3 and S4, the centrifugation step after the reaction with the activator is performed at a speed of 10,500 rpm for 15 to 25 min.
[0032] The third aspect of the present invention provides the application of the near-infrared light FRET biosensor based on rare earth ion-doped nanocrystals described in the first aspect in homogeneous detection, and the detected indicators include small molecule indicators (such as morphine, MOP), protein indicators (such as human chorionic gonadotropin, β-HCG) or virus particle indicators (such as adenovirus, AdV).
[0033] The near-infrared FRET sensor of the present invention can realize homogeneous detection of small molecule indicators (such as morphine MOP and VD), protein indicators (such as human chorionic gonadotropin, β-HCG) and virus particle indicators (such as adenovirus, AdV) without background interference. The near-infrared FRET sensor can realize high-sensitivity and high-precision homogeneous detection of indicators in complex samples such as urine, feces, whole blood, pleural effusion, sewage and food safety testing samples.
[0034] Preferably, the detection method comprises the following steps:
[0035] S1, after the Tris buffer, the probe 1 labeled with the antibody or antigen and the test sample are fully reacted, the near-infrared light emission intensity of the donor nanocrystal is measured, which is recorded as I0;
[0036] S2, adding probe 2 labeled with antibody or antigen, incubating appropriately to ensure sufficient reaction, and then measuring the near-infrared light emission intensity of the donor nanocrystal, which is recorded as I;
[0037] S3: Determine the detection limit of the near-infrared FRET sensor and fit the working curve of the near-infrared FRET sensor;
[0038] S4: By judging the relationship between [I / I0] and the detection limit, the content of the detection target in the sample to be tested can be determined.
[0039] Preferably, the method for determining the detection limit in step S3 is as follows: the detection standard target of different concentrations is determined by the method of steps S1 and S2, the experiment is repeated three times, the mean and standard deviation are calculated, and a standard curve is established, wherein the detection limit = blank sample mean + 3 × blank sample standard deviation, and the blank sample is a sample with a detection index concentration of 0.
[0040] Preferably, the incubation condition in step S2 is 1 to 10 min at 37° C.; the concentrations of the probe 1 solution labeled with the antibody in step S1 and the probe 2 solution labeled with the antigen in step S2 are both 0.5 to 10 mg / mL.
[0041] Compared with the prior art, the present invention has the following beneficial effects:
[0042] The present invention discloses a rare earth fluoride nano-fluorescent crystal near-infrared light donor and acceptor pair for background-free homogeneous detection, and a rare earth-based near-infrared fluorescence FRET sensor for high-sensitivity homogeneous detection is constructed based on the donor and acceptor pair. The probe system of the FRET sensor includes a probe 1 and a probe 2. The probe 1 is Nd 3+ With Yb 3+ Co-doped rare earth fluoride nanocrystals, wherein the probe 2 is Yb 3+ Doped rare earth fluoride nanocrystals. The present invention greatly improves the FRET efficiency of the near-infrared FRET sensor by designing the structure of probe 1 and designing probe 2 as rare earth fluoride nanocrystals, and greatly improves the photochemical stability and anti-interference ability of the near-infrared FRET sensor. At the same time, the present invention also constructs a near-infrared FRET sensor that can be used for the detection of small molecule indicators such as morphine (MOP), protein indicators such as human chorionic gonadotropin (β-HCG), and viral particle indicators such as adenovirus (AdV), and realizes highly sensitive homogeneous detection of indicators in complex samples such as urine, feces and whole blood. The method has the advantages of simple operation, short detection time, background-free detection, and rapidity, specificity, high selectivity, high sensitivity and high throughput. The present invention has the following advantages:
[0043] (1) Probe 1 of the present invention, Nd 3+ With Yb 3+ Co-doped rare earth fluoride nanocrystals - NaYF4@NaYF4:Ndx% / Yby%, this structure can concentrate the luminescence center of the donor rare earth material on the luminescent layer. Because the FRET efficiency is inversely proportional to the sixth power of the donor-acceptor distance, the structure of the present invention can greatly shorten the distance between the luminescence center and the acceptor quencher, greatly improving the FRET efficiency. And thanks to Nd 3+ With Yb 3+ Efficient energy transfer with Nd 3+ For 808nm efficient absorption, it can greatly enhance the Yb 3+ A major advantage of the present invention is that the probe takes into account both the donor fluorescence intensity and the FRET efficiency.
[0044] (2) Probe 2 is Yb 3+ Doped rare earth fluoride nanocrystals - NaLnF4:Ybx%, using Yb with great spectral overlap with probe 1 and high energy absorption 3+ As a doping element for rare earth fluoride nanocrystals, it can achieve higher efficiency when forming a FRET system due to its smaller volume, higher specific surface area, and smaller steric hindrance effect. More importantly, the receptor Yb 3+When doped highly, it can not only enhance the absorption capacity of the acceptor material and improve the FRET efficiency, but also reduce the emission of the acceptor or even eliminate it as much as possible due to the energy migration effect, thus avoiding the interaction with the donor Yb 3+ spectral crosstalk.
[0045] (3) A near-infrared FRET sensor composed entirely of rare earth nanoparticles and used for highly sensitive homogeneous detection, which is composed of probes 1 and 2. Using NaYF4@NaYF4:Ndx% / Yby% as a donor, under 808nm excitation, it emits 980nm light in the near-infrared II region (NIR-II). Biological tissues basically do not absorb the luminescence in this region, and can realize the detection of various environments and various targets.
[0046] (4) The near-infrared FRET sensor constructed using this method can detect a variety of biomarkers in various environments. It has the characteristics of rapidity, specificity, convenience, high selectivity and high throughput. It can be used for the detection of various types of targets such as small molecule indicators (such as MOP, VD), protein indicators (such as β-HCG), and viral particle indicators (such as AdV). For MOP detection, the detection limit is 0.96 ng / mL; for VD detection, the detection limit is 0.48 ng / mL; for β-HCG detection, the detection limit is 0.36 U / L; for AdV detection, the detection limit is 1.4×10 4 The above results show that the FRET sensor not only has the characteristics of high sensitivity, but also can realize high-throughput rapid quantitative detection of target substances. BRIEF DESCRIPTION OF THE DRAWINGS
[0047] Figure 1 (a) is a representative transmission electron micrograph of NaYF4@NaYF4:Ndx% / Yby% (i.e., NaYF4@NaYF4:Nd40% / Yb10%); (b) is a representative transmission electron micrograph of α-NaYbF4 (i.e., cubic phase NaYbF4); (c) is a representative X-ray diffraction pattern of NaYF4@NaYF4:Ndx% / Yby% and NaLnF4:Ybx% (i.e., α-NaYbF4).
[0048] Figure 2(a) is the normalized excitation and emission spectra of β-Y@Y:Nd40% / Yb10% (i.e., hexagonal phase NaYF4@NaYF4:Nd40% / Yb10%) and the normalized absorption spectrum of α-Yb acceptor (i.e., cubic phase NaYbF4); (b) is the normalized emission spectrum of Y@Y:Nd / Yb (i.e., NaYF4@NaYF4:Nd40% / Yb10%) and the normalized absorption spectra of α-Yb20% (i.e., NaYF4:20%Yb) and α-Yb100% (α-NaYbF4); (c) is the normalized emission spectra of α-NaYF4:20%Yb and α-NaYbF4.
[0049] Figure 3 (a) is the spectrum diagram when NaYF4@NaYF4:Nd / Yb exists alone and when NaYF4@NaYF4:Nd / Yb and NaYbF4 exist at the same time in a 1:1 ratio; (b) is the transmission electron microscopy image taken after the antigen-antibody FRET biosensor was constructed.
[0050] Figure 4 (a) is a schematic diagram of the MOP or VD detection process (competitive method); (b) is a schematic diagram of the β-HCG or AdV detection process (double antibody sandwich method).
[0051] Figure 5 (a) is a standard curve diagram for detecting standard substances using the near-infrared FRET sensor, and the standard curve and the detection limit of the sensor are established by using [I / I0] and the concentration of MOP; (b) is a standard curve diagram for detecting standard substances using the near-infrared FRET sensor, and the standard curve and the detection limit of the sensor are established by using [I / I0] and the concentration of VD; (c) is a standard curve diagram for detecting standard substances using the near-infrared FRET sensor, and the standard curve and the detection limit of the sensor are established by using [I / I0] and the concentration of β-HCG; (d) is a standard curve diagram for detecting standard substances using the near-infrared FRET sensor, and the standard curve and the detection limit of the sensor are established by using [I / I0] and the concentration of AdV. DETAILED DESCRIPTION
[0052] The specific embodiments of the present invention are further described below. It should be noted that the description of these embodiments is used to help understand the present invention, but does not constitute a limitation of the present invention. In addition, the technical features involved in each embodiment of the present invention described below can be combined with each other as long as they do not conflict with each other.
[0053] The experimental methods in the following examples are conventional methods unless otherwise specified, and the experimental materials used in the following examples are commercially available unless otherwise specified.
[0054] Example 1 Preparation of near-infrared luminescent NaYF4@NaYF4:Nd40% / Yb10% donor nanoparticles and NaYbF4 acceptor nanoparticles
[0055] 1. Preparation of NaYF4@NaYF4:Nd40% / Yb10% donor nanoparticles
[0056] (1) Preparation of inert core NaYF4
[0057] The first typical synthesis method of NaYF4: 1mmolYAc3·4H2O, 7.5mLOA, and 15.0mLLODE were added to a 100mL three-necked flask one by one and stirred vigorously. The entire reaction system was heated to 160°C under nitrogen protection for 45 minutes and then cooled to room temperature. Next, 10mL methanol solution containing 2.5mmolNaOH and 4.0mmolNH4F was added to the reaction system. Then, the entire reaction system was raised to 120°C for 20 minutes to completely remove water, methanol, and oxygen from the reaction system. Subsequently, it was heated to 300°C under nitrogen protection and continued to react for 60 minutes. Finally, the reaction system was cooled to room temperature, the resulting product was collected by centrifugation (8,000rpm, 4min), washed 1-3 times with anhydrous ethanol, and then dispersed in 10mL cyclohexane.
[0058] The second typical synthesis method of NaYF4: 1mmol of Y(CF3COO)3, 1mmol of CF3COONa, 10mLOA, and 10mL ODE are successively added to a 100mL three-necked flask and stirred vigorously. The entire reaction system is heated to 120°C for 15min under nitrogen protection. To completely remove water and oxygen in the reaction system. Subsequently, it is heated to 300°C under nitrogen protection and the reaction is continued for 30min. Finally, the reaction system is cooled to room temperature, the resulting product is collected by centrifugation (8,000rpm, 4min), and washed with ethanol 1-3 times. Then dispersed in 10mL cyclohexane.
[0059] (2) Wrapping the luminescent shell on the inert core to synthesize the nanoparticles NaYF4@NaYF4:Nd40% / Yb10%
[0060] The first synthesis process of the core-shell structure: using the inert core particles in step (1) as seeds, synthesize the core-shell structure of NaYF4@NaYF4:Nd40% / Yb10%. The specific operation steps are: 0.75mmolLnAc3 (Ln=Y, Nd, Yb, the mass proportions of the three are 50%, 40%, 10% respectively), 7.5mLOA, 15.0mLLODE are added to a 100mL three-necked flask one by one, and stirred vigorously. The entire reaction system is heated to 160℃ under nitrogen protection for 45min and then cooled to room temperature. Next, 10mL methanol solution containing 2.0mmolNaOH and 3.0mmolNH4F is added to the reaction system. Then, the entire reaction system is raised to 120℃ for 20min to completely remove water, methanol and oxygen in the reaction system. Subsequently, it is heated to 300℃ under nitrogen protection and the reaction is continued for 60min. Finally, the reaction system was cooled to room temperature, and the resulting product was collected by centrifugation (8,000 rpm, 4 min), washed with ethanol 1-3 times, and then dispersed in 10 mL of cyclohexane.
[0061] The second synthesis process of the core-shell structure: using the inert core particles in step (1) as seeds, synthesize the core-shell structure of NaYF4@NaYF4:Nd40% / Yb10%. The specific operation steps are: 0.75mmol of Ln(CF3COO)3 (Ln=Y, Nd, Yb, the mass proportions of the three are 50%, 40%, 10% respectively), CF3COONa (0.102g), OA (10mL) and ODE (10mL) and 5mL cyclohexane solution of prepared NaYF4 are mixed. The reaction system is heated to 120℃ for 10min to completely remove water and oxygen from the reaction system. Finally, under nitrogen protection, the reaction temperature is raised to 300℃ and the reaction is carried out for 30min. After cooling to room temperature, centrifugation (8,000rpm, 4min) is performed to collect. Finally, the prepared NaYF4@NaYF4:Nd40% / Yb10% was dispersed in 5 mL of cyclohexane for further use.
[0062] 2. Preparation of NaYbF4 acceptor (i.e., NaLnF4:Ybx%, where x=100; or α-NaYbF4) nanoparticles
[0063] The steps for preparing NaYbF4 nanoparticles are as follows: 1mmol of YbAc3·4H2O, 7.1mL ODE, 3.5mL OA and 3.9mL OM are added to a 100mL three-necked flask. Under the protection of nitrogen, the reaction is heated to 160℃ and stirred vigorously for 30min. When the reaction system is cooled to room temperature, 10mL methanol solution containing 2.5mmol NaOH and 4.0mmol NH4F is added to the reaction system. The entire reaction is heated to 120℃ and maintained for 20min to remove water and air from the reaction system. The reaction is then heated to 300℃ and reacted for 30min under nitrogen protection. Then, ethanol is added to the reaction system for full precipitation, and the resulting product is collected by centrifugation (7,500rpm, 5 minutes), washed with ethanol 1-3 times, and finally dispersed in 10mL cyclohexane for use.
[0064] The NaYF4@NaYF4:Nd40% / Yb10% core-shell structure nanocrystals and NaYbF4 nanoparticles prepared in this example were characterized by transmission electron microscopy. Figure 1 As shown in a and 1b, it shows that the nanoparticles are monodisperse and have a uniform size distribution. Among them, the size of NaYF4@NaYF4:Nd5% is about 29.1nm, and the size of NaYbF4 is about 10.5nm. The NaYF4@NaYF4:Nd40% / Yb10% and NaYbF4 prepared in this experiment were subjected to X-ray diffraction analysis. Figure 1 The XRD diffraction spectrum shown in c shows that NaYF4@NaYF4:Nd40% / Yb10% nanocrystals have a hexagonal crystal structure and NaYbF4 has a cubic crystal structure.
[0065] Yb 3+ The normalized absorption spectrum of the acceptor nanocrystal with doping concentration (10%) and the emission spectrum of the donor material are shown in Figure 2 As shown in a, due to its smaller volume, higher specific surface area, and smaller steric hindrance effect, it can achieve higher efficiency when forming a FRET system. More importantly, the receptor Yb 3+ When doped to a high degree (100%), it can not only enhance the absorption capacity of the acceptor material and improve the FRET efficiency, but also reduce the emission of the acceptor as much as possible or even eliminate it due to the energy migration effect. Figure 2 b, c, thus avoiding the interaction with the donor Yb 3+ Example 2 Application of NaYF4@NaYF4:Nd40% / Yb10% donor nanoparticles and NaYbF4 acceptor nanoparticles in the preparation of near-infrared FRET sensors
[0066] (1) This embodiment provides an automatic near-infrared FRET sensor, comprising Nd labeled with an antibody 3+ With Yb 3+ Co-doping of rare earth fluoride nanocrystals and Yb labeled with antigens 3+ Rare earth doped luminescent nanocrystals; wherein the antibody and the antigen are antigen-antibody pairs that can undergo specific binding reactions. In the present invention, any antigen-antibody pair that can theoretically undergo specific binding reactions, or any double antibody pair that can act on the antigen to be tested, can be used: for example, the antibody connected to the donor can be a VD antibody, a MOP antibody (Ab MOP ), acetylcholine antibody 1, human chorionic gonadotropin (β-HCG) antibody 1, etc. The receptor-linked antigen can be VD antigen, MOP antigen (Ag MOP ) etc.; at the same time, the donor-linked antibody can also be acetylcholine antibody 1, human chorionic gonadotropin (β-HCG) antibody 1, adenovirus (AdV) antibody 1, dengue fever antibody 1, etc., and the receptor-linked antigen can also be acetylcholine antibody 2, human chorionic gonadotropin (β-HCG) antibody 2, adenovirus (AdV) antigen 2, dengue fever antigen 2, etc. In the present invention, Ab MOP and Ag MOP ,Ab AdV1 and Ab AdV2 ,Ab β-HCG1 and Ab β-HCG2 ,Ab VD and Ag VD Take four antigen-antibody pairs or double antibody pairs with different interaction modes (purchased from commercial companies, such as Yibaixin Bio, Feipeng Bio Co., Ltd., etc.) as examples.
[0067] 5mL HCl (0.1mmol / mL) and 5mL anhydrous ethanol were added to a 50mL centrifuge tube with OA-coated NaYF4@NaYF4:Nd40% / Yb10% and shaken. After standing for 24h, the reaction was completed and ligand-free NaYF4@NaYF4:Nd40% / Yb10% was obtained, which was collected by centrifugation (10,500rpm, 30min). Then dispersed in 5mL deionized water. Next, 10mL polyacrylic acid (PAA, 1.0%) aqueous solution was added to a 50mL beaker, and then the ligand-free NaYF4@NaYF4:Nd40% / Yb10% nanoparticle solution was added dropwise to the beaker. After stirring at room temperature for 30min, the PAA-modified NaYF4@NaYF4:Nd40% / Yb10% with rich surface carboxyl groups was collected by centrifugation (10,500rpm, 15min). Subsequently, it was washed three times with MES solution (0.05 M, pH = 6.0) to remove excess PAA molecules in the system, and then dispersed in 5 mL of MES solution.
[0068] Take 100μL of the newly prepared NaYF4@NaYF4:Nd40% / Yb10%-PAA solution and put it into a 1.5mL centrifuge tube, and dilute it to 500μL with MES buffer. Add 40μL of 10mg / mL EDC solution to it, and then add 65μL of 10mg / mL NHS solution to it. Place it on a shaking plate for half an hour to speed up the reaction. Collect the activated NaYF4@NaYF4:Nd40% / Yb10%-PAA by centrifugation (10,500rpm, 15min), wash it three times with MES buffer to remove excess EDC and NHS. MOP Mix with the activated NaYF4@NaYF4:Nd40% / Yb10%-PAA in 500μL of MES buffer and shake the mixture to make it fully react. After 2h, add 500μL of glycine buffer containing 2% BSA in a 1.5mL centrifuge tube and react for another 30 minutes. Finally, collect the prepared NaYF4@NaYF4:Nd40% / Yb10%-Ab by centrifugation (16,000rpm, 15min). MOP , washed twice with glycine buffer, and finally dispersed in 100 μL Tris buffer (100 mM, pH = 7.4).
[0069] At the same time, NaYbF4-Ag MOP ,NaYF4@NaYF4:Nd40% / Yb10%-Ab AdV1 、NaYbF4-Ab AdV2 ,NaYF4@NaYF4:Nd40% / Yb10%-Ab β-HCG1 、NaYbF4-Ab β-HCG2 ,NaYF4@NaYF4:Nd40% / Yb10%-Ab VD 、NaYbF4-Ag VD The preparation process is similar to that of NaYF4@NaYF4:Nd40% / Yb10%-Ab MOP The preparation process is the same as that of the antibody, except that the donor and receptor and the antigen and antibody are replaced respectively.
[0070] (2) A biosensor constructed based on the FRET principle comprises the following steps:
[0071] NaYF4@NaYF4:Nd40% / Yb10%-Ab MOP and NaYbF4-Ag MOP The core FRET system of the near-infrared FRET sensor of the present invention is obtained by mixing in a ratio of 1:1.MOP When excited at 808nm, there is obvious Yb 3+ The emission light of 950~1100nm is completed when NaYbF4-AgMOP exists. 3+ The emission is significantly reduced, such as Figure 3 As shown in a. At the same time, the transmission electron microscope was taken of the constructed FRET system, as shown in Figure 3 As shown in b, it was found that the donor and acceptor were tightly bound together. AdV1 and NaYbF4-Ab AdV2 The core FRET system of the near-infrared FRET sensor of the present invention is obtained by mixing in a ratio of 1:1. AdV1 When excited at 808nm, there is obvious Yb 3+ The emission light of 950~1100nm, when NaYbF4-Ab appears in the solution AdV2 When the near-infrared FRET is constructed, its Yb 3+ The emission is significantly reduced. In addition, NaYF4@NaYF4:Nd40% / Yb10%-Ab β-HCG1 and NaYbF4-Ab β-HCG2 ,NaYF4@NaYF4:Nd40% / Yb10%-Ab VD and NaYbF4-Ag VD It also has the same infrared FRET phenomenon.
[0072] Example 3: The near-infrared FRET biosensor of the present invention is used for the detection of MOP, VD, β-HCG and AdV
[0073] (1) Operational procedures of the novel near-infrared FRET sensor for detecting MOP in urine (e.g. Figure 4 a):
[0074] 160 μL Tris-HCl buffer and 10 μL NaYF4@NaYF4:Nd40% / Yb10%-Ab MOP (0.5mg / mL) solution was added to the well plate in sequence. Then 20μL of urine sample was added to the well plate and shaken thoroughly. The instrument reading was recorded as I0. 10μL NaYbF4-Ag was added to the well plate. MOP(0.5mg / mL) solution, incubate at 37℃ for 5min to ensure the reaction is complete. The instrument (multi-channel fluorescence analyzer) reading is recorded as I, and the test result is expressed as [I / I0]. When [I / I0] is greater than the detection limit of the system, it is considered that the clinical blood sample contains MOP, and the closer the [I / I0] value is to 1, the higher the MOP content in the sample. The instrument is easy to operate and has the advantage of being suitable for a variety of complex environments.
[0075] (2) Operational procedures of the novel near-infrared FRET sensor for detecting vitamin D (VD) in whole blood (e.g. Figure 4 a):
[0076] 160 μL Tris-HCl buffer and 10 μL NaYF4@NaYF4:Nd40% / Yb10%-Ab VD (0.5mg / mL) solution was added to the well plate in sequence. Then 20μL of whole blood sample was added to the well plate and shaken thoroughly. The instrument reading was recorded as I0. 10μL NaYbF4-Ag was added to the well plate. VD (0.5 mg / mL) solution, incubate at 37°C for 5 minutes to ensure the reaction is complete. The instrument (multi-channel fluorescence analyzer) reading is recorded as I, and the test result is expressed as [I / I0]. When [I / I0] is greater than the detection limit of the system, it is considered that the clinical blood sample contains VD. The closer the [I / I0] value is to 1, the higher the VD content in the sample. The instrument is easy to operate and has the advantage of being suitable for a variety of complex environments. Homogeneous detection of biomarkers in complex samples has broad application scenarios and a bright future.
[0077] (3) Operational procedures of the novel near-infrared FRET sensor for detecting human chorionic gonadotropin (β-HCG) in whole blood (e.g. Figure 4 b):
[0078] 160 μL Tris-HCl buffer and 10 μL NaYF4@NaYF4:Nd40% / Yb10%-Ab β-HCG1 (0.5mg / mL) solution was added to the well plate in sequence. Then 20μL of whole blood sample was added to the well plate and shaken thoroughly. The instrument reading was recorded as I0. 10μL NaYbF4-Ab was added to the well plate. β-HCG2 (0.5mg / mL) solution, incubate at 37℃ for 5min to ensure the reaction is complete. The instrument reading is recorded as I, and the test result is expressed as [I / I0]. When [I / I0] is less than the detection limit of the system, it is considered that the whole blood sample contains β-HCG. The closer the [I / I0] value is to 1, the less β-HCG content there is in the sample. The instrument is easy to operate and has the advantage of being suitable for a variety of complex environments. Homogeneous detection of biomarkers in complex samples has broad application scenarios and a bright future.
[0079] (4) Operational procedures of the novel near-infrared FRET sensor for detecting adenovirus (AdV) in feces (e.g. Figure 4 b):
[0080] 160 μL Tris-HCl buffer and 10 μL NaYF4@NaYF4:Nd40% / Yb10%-Ab AdV1 (0.5mg / mL) solution was added to the well plate in sequence. Then 20μL of the fecal dilution sample was added to the well plate and shaken thoroughly. The instrument reading was recorded as I0. 10μL NaYbF4-Ab was added to the well plate. AdV2 (0.5mg / mL) solution, incubate at 37℃ for 5min to ensure the reaction is complete. The instrument reading is recorded as I, and the test result is expressed as [I / I0]. When [I / I0] is less than the detection limit of the system, it is considered that the fecal sample contains AdV. The closer the [I / I0] value is to 1, the less AdV content in the sample. The instrument is easy to operate and has the advantage of being suitable for a variety of complex environments. Homogeneous detection of biomarkers in complex samples has broad application scenarios and a bright future.
[0081] This new type of near-infrared FRET sensor has the advantages of being simple to use, easy to operate, and suitable for a variety of complex environments, so it has broad application prospects in the detection of biomarkers. This sensor can avoid the problems of spectral overlap and background interference in traditional FRET sensors, and can make the detection results more reliable and accurate. Therefore, the application prospects of this instrument are very broad, and it can play an important role in the fields of drug development, clinical diagnosis, and bioanalysis. It is worth noting that this near-infrared FRET sensor can not only be used for the detection of MOP, but any life marker that can specifically block the specific binding between antigens and antibodies or can make the two antibodies not affect each other while acting together with the antigen can be detected by this sensor.
[0082] (5) Determination of the detection limit of the new near-infrared FRET sensor for MOP in urine
[0083] The urine containing a certain standard concentration (0, 1, 2.5, 5, 7.5, 10, 25, 50, 75, 100, 200 ng / mL) of MOP standard was detected using a near-infrared FRET sensor, and all data points were measured three times. In order to obtain the standard curve and detection limit of the near-infrared FRET sensor, the mean and standard deviation (SD) of the blank group must be determined first. The standard curve was established using the MOP concentration and luminescence intensity [I / I0]. In addition, the detection limit (LoD) was calculated as LoD = blank mean + 3 × blank standard deviation. The results are shown in the figure below. Figure 5As shown in a, the near-infrared FRET sensor constructed using the present invention exhibits a good linear relationship in detecting MOP in urine, laying a solid foundation for the detection application of clinical samples of other biological targets, and exhibits a low detection limit, strongly reflecting the superiority of homogeneous detection.
[0084] (6) Determination of the detection limit of VD in whole blood using a new near-infrared FRET sensor
[0085] A near-infrared FRET sensor was used to detect whole blood samples containing a certain standard concentration of VD (0, 0.68, 1.36, 2.04, 2.73, 3.40, 6.80, 13.60, 20.40 ng / mL), and all data points were measured three times. In order to obtain the standard curve and detection limit of the near-infrared FRET sensor, the mean and standard deviation (SD) of the blank group must be determined first. The standard curve is established using VD concentration and luminescence intensity [I / I0]. In addition, the detection limit (LoD) is calculated as LoD = blank mean + 3 × blank standard deviation. The results are shown in the figure. Figure 5 As shown in FIG. 2 , the near-infrared FRET sensor constructed using the present invention exhibits a good linear relationship in detecting VD in whole blood, laying a solid foundation for the detection application of clinical samples of other biological targets, and exhibits a low detection limit, strongly reflecting the superiority of homogeneous detection.
[0086] (7) Determination of the detection limit of β-HCG in whole blood using a new near-infrared FRET sensor
[0087] A near-infrared FRET sensor was used to detect whole blood samples containing a certain standard concentration of β-HCG (0, 0.32, 0.64, 1.28, 2.56, 5.12, 10, 30, 90, 270, 810 U / L), and all data points were measured three times. In order to obtain the standard curve and detection limit of the near-infrared FRET sensor, the mean and standard deviation (SD) of the blank group must be determined first. The standard curve was established using the β-HCG concentration and luminescence intensity [I / I0]. In addition, the detection limit (LoD) was calculated as LoD = blank mean + 3 × blank standard deviation. The results are shown in the figure. Figure 5 As shown in Figure c, the near-infrared FRET sensor constructed using the present invention shows a good linear relationship in detecting β-HCG in whole blood, laying a solid foundation for the detection application of clinical samples of other biological targets, and exhibits a low detection limit, strongly reflecting the superiority of homogeneous detection.
[0088] (8) Determination of the detection limit of AdV in fecal extract using a new near-infrared FRET sensor
[0089] The near-infrared FRET sensor was used to detect the presence of a certain standard concentration (0, 38.5, 385, 3.85x10 3,3.85x10 4 ,3.85x10 5 ,3.85x10 6 ,3.85x10 7 ,3.85x10 8 ,3.85x10 9 Vp / mL) of AdV fecal extract, all data points were measured three times. In order to obtain the standard curve and detection limit of the near-infrared FRET sensor, the mean and standard deviation (SD) of the blank group must be determined first. The standard curve was established using MOP concentration and luminescence intensity [I / I0]. In addition, the detection limit (LoD) was calculated as LoD = blank mean + 3 × blank standard deviation. The results are shown in Figure 5 As shown in Figure d, the near-infrared FRET sensor constructed using the present invention exhibits a good linear relationship in detecting AdV in feces, laying a solid foundation for the detection application of clinical samples of other biological targets, and exhibits a low detection limit, strongly reflecting the superiority of homogeneous detection.
[0090] The embodiments of the present invention are described in detail above, but the present invention is not limited to the described embodiments. For those skilled in the art, various changes, modifications, substitutions and variations of these embodiments are made without departing from the principles and spirit of the present invention, and still fall within the protection scope of the present invention.
Claims
1. A near-infrared FRET biosensor based on rare earth ion-doped nanocrystals, characterized in that: The near-infrared FRET biosensor comprises a probe 1 labeled with an antibody or an antigen and a probe 2 labeled with an antibody or an antigen, wherein the antibody and the antigen are an antigen-antibody pair capable of undergoing a specific binding reaction; the probe 1 is Nd 3+ With Yb 3+ Co-doped rare earth fluoride nanocrystals, specifically NaLnF4@NaLnF4:Ndx% / Yby%, with a core-shell structure, wherein x=20-60, y=5-20; the probe 2 is Yb 3+ Doped rare earth fluoride nanocrystals, specifically NaLnF4:Ybx%, wherein x=100.
2. The method for constructing a near-infrared FRET biosensor based on rare earth ion-doped nanocrystals according to claim 1, characterized in that: The following steps are involved: S1. Preparation of Nd 3+ With Yb 3+ Co-doped rare earth fluoride nanocrystals: S11. Prepare the inert core NaLnF4 by the method of S11-1 or S11-2: S11-1, rare earth acetate, oleic acid and 1-octadecene are uniformly mixed, heated to a first temperature under an inert atmosphere, reacted for 45±15 min, cooled, added with a methanol solution containing sodium hydroxide and ammonium fluoride, heated to a second temperature under an inert atmosphere, and after the methanol, oxygen and water in the system are completely removed, heated to a third temperature again, reacted for 75±15 min, cooled, centrifuged, collected the product, washed with ethanol for 1-3 times, and dispersed in a dispersant to obtain NaLnF4 nanoparticles; S11-2, uniformly mixing trifluoroacetic acid rare earth salt, sodium trifluoroacetate, oleic acid and 1-octadecene, heating to a first temperature under an inert atmosphere, reacting for 20±15 min, heating to a second temperature under an inert atmosphere, reacting for 45±15 min, cooling and centrifuging to collect the product, washing with ethanol 1-3 times, and dispersing in a dispersant to obtain NaLnF4 nanoparticles; S12, using the method of S12-1 or S12-2 to prepare core-shell structure NaLnF4@NaLnF4:Ndx% / Yby% nanocrystals: S12-1, rare earth acetate, oleic acid and 1-octadecene are uniformly mixed, heated to a first temperature under an inert atmosphere, reacted for 45±15 min, cooled, added with a methanol solution containing sodium hydroxide and ammonium fluoride and the NaLnF4 nanoparticles synthesized in S11, heated to a second temperature under an inert atmosphere, and after the methanol, oxygen and water in the system are completely removed, heated to a third temperature again, reacted for 75±15 min, cooled, centrifuged and collected the product, washed with ethanol for 1-3 times, and dispersed in a dispersant to obtain NaLnF4@NaLnF4:Ndx% / Yby% nanoparticles; S12-2, uniformly mix trifluoroacetic acid rare earth salt, sodium trifluoroacetate, oleic acid and 1-octadecene, heat to a first temperature under an inert atmosphere, react for 20±15 min, add a methanol solution containing sodium hydroxide and ammonium fluoride and the NaLnF4 nanoparticles synthesized in S3 after cooling, heat to a second temperature under an inert atmosphere, react for 45±15 min, collect the product by centrifugation after cooling, wash with ethanol for 1-3 times, and disperse in a dispersant to obtain the NaLnF4@NaLnF4:Ndx% / Yby% nanoparticles; S2, Synthesis of Yb 3+ Doped rare earth fluoride nanocrystals: Rare earth acetate, oleic acid, 1-octadecene and oleylamine are uniformly mixed, heated to a first temperature under an inert atmosphere, reacted for 45±15 minutes, cooled, added with a methanol solution containing sodium hydroxide and ammonium fluoride, heated to a second temperature under an inert atmosphere, and after the methanol, oxygen and water in the system are completely removed, heated to a third temperature again, reacted for 45±15 minutes, cooled, centrifuged, collected the product, washed with ethanol 2-3 times, and dispersed in a dispersant to obtain NaLnF4:Ybx% particles; S3, Nd of step S1 3+ With Yb 3+ The co-doped rare earth fluoride nanocrystals are labeled with antibodies or antigens, thereby obtaining probes 1 labeled with antibodies or antigens; S4, Yb in step S2 3+ The doped rare earth fluoride nanocrystals are labeled with antibodies or antigens to obtain probes 2 labeled with antibodies or antigens.
3. The method for constructing a near-infrared FRET biosensor based on rare earth ion-doped nanocrystals according to claim 2, characterized in that: In S11-1, the rare earth element is yttrium, the inert gas is nitrogen, the first temperature is 155±15°C, the second temperature is 120±20°C, the third temperature is 300±20°C, the dispersant is cyclohexane, and the amounts of the rare earth acetate, oleic acid and 1-octadecene are 0.25~1.0mmol:5~10mL:10~20mL; in S11-2, the rare earth element is yttrium, the inert gas is nitrogen, the first temperature is 120±20°C, the second temperature is 300±20°C, the dispersant is cyclohexane, and the amounts of the rare earth acetate, oleic acid and 1-octadecene are 0.25~1.0mmol:5~10mL:10~20mL.
4. The method for constructing a near-infrared FRET biosensor based on rare earth ion-doped nanocrystals according to claim 2, characterized in that: In S12-1, the rare earth element is yttrium, neodymium or ytterbium, the inert gas is nitrogen, the first temperature is 155±15°C, the second temperature is 120±20°C, the third temperature is 300±20°C, the dispersant is cyclohexane, and the amount of the acetate, oleic acid and 1-octadecene of the rare earth element is 0.25~1.0mmol:5~10mL:10~20mL; in S12-2, the rare earth element is yttrium, neodymium or ytterbium, the inert gas is nitrogen, the first temperature is 120±20°C, the second temperature is 300±20°C, and the dispersant is cyclohexane; the amount of the acetate, oleic acid and 1-octadecene of the rare earth element is 0.25~1.0mmol:5~10mL:10~20mL.
5. The method for constructing a near-infrared FRET biosensor based on rare earth ion-doped nanocrystals according to claim 2, characterized in that: In S2, the rare earth element is ytterbium, the inert gas is nitrogen, the first temperature is 155±15°C, the second temperature is 120±20°C, the third temperature is 300±15°C, the dispersant is cyclohexane, and the ratio of rare earth acetate, oleic acid, 1-octadecene and oleylamine is 0.25~1.0mmol:1~5mL:2~10mL:1~5mL.
6. Application of the near-infrared FRET biosensor based on rare earth ion-doped nanocrystals in homogeneous detection according to claim 1, characterized in that: The detected indicators include small molecule indicators, protein indicators or virus particle indicators.
7. The use according to claim 6, characterized in that: The detection method includes the following steps: S1, after the buffer, the probe 1 labeled with the antibody or antigen and the test sample are fully reacted, the near-infrared light emission intensity of the donor nanocrystal is measured, which is recorded as I0; S2, adding probe 2 labeled with antibody or antigen, incubating appropriately to ensure sufficient reaction, and then measuring the near-infrared light emission intensity of the donor nanocrystal, which is recorded as I; S3, after the samples containing different concentrations of the target to be tested are measured by the near-infrared FRET sensor, [I / I0] is obtained, and then the working curve of the near-infrared FRET sensor with different concentrations of the target to be tested is fitted; S4. Based on the relationship between [I / I0] of the sample to be tested and the concentration of the analyte, the content of the analyte in the sample to be tested can be inferred.
Citation Information
Cited By
Fluorescence resonance energy transfer probe system and method for high-sensitivity homogeneous immunodetection of rice yeast acid in whole blood
CN120847407A
A fluorescence resonance energy transfer probe system and a method for high-sensitivity homogeneous immunoassay of mycophenolic acid in whole blood
CN120847407B
